Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIB4920 in Sjögren's Syndrome
NCT04129164Phase 2Completed
- Sponsor
- Amgen
- Start
- Dec 2019
- Primary completion
- Sep 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 12
01
Overview
A Phase 2 trial of dazodalibep in Sjögren's syndrome, sponsored by Amgen. Started Dec 2019; status: completed.
02
Drugs
dazodalibep
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT04129164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04129164.